Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-11-18

FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC, approving this generic lisinopril product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lisinopril (Lisinopril)

Snippet

SUPPL AP for LISINOPRIL (LISINOPRIL)